Dr. Mark Christopher Deleon, MD

Dr. Deleon practices at Ascension Sacred Heart Pensacola in Pensacola, Florida, part of Ascension Health Alliance.

Dr. Deleon's NPI, 1174557649, was assigned on July 10, 2006. Dr. Deleon graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 1989. Dr. Deleon holds Florida license ME146938.

Dr. Deleon's primary practice is Ascension Sacred Heart Pensacola, at 5151 N 9th Ave, Pensacola, FL 32504 in Escambia County. The practice phone is (850) 416-7000.

Dr. Deleon's primary practice is Ascension Sacred Heart Pensacola in Pensacola, Florida, part of Ascension Health Alliance. Dr. Deleon is also affiliated with Ascension Sacred Heart Bay. The medical group on file is Sacred Heart Medical Group. Dmand AI also links Dr. Deleon to 3 more hospitals, 1 clinical lab, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deleon practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Deleon's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Deleon is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Deleon's licenses on file in 3 states: Florida, Texas and Louisiana.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Deleon treats.

CMS data shows 1,342 Medicare services from Dr. Deleon across 8 procedure codes in 2024, for 470 Medicare patients. Medicare paid $86,248 for them. Every service was in an office.

CMS counts 470 Medicare patients who saw Dr. Deleon in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Deleon's median patient age at 73, with 58% women.

In 2024, Dr. Deleon wrote 1,323 Medicare Part D claims for 266 patients. 76% of them were for generic drugs. CMS names the drug for 1,061 of them, across 36 drugs with 11 or more claims each, at $3,148,085 in total drug cost. In 2023, CMS named 661 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Deleon for performance year 2024, reported through an alternative payment model (APM). Dr. Deleon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deleon as offering telehealth.

CMS Open Payments shows 497 general payments to Dr. Deleon from 66 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 73% of the total. Gilead Sciences, Inc. paid the most, $3,702.

Dr. Deleon graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 1989.

Dr. Deleon is in network with 23 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. HMO plans come from the most carriers, 14. Check the plan with the practice before a visit.